Aflibercept (INN, USAN) is a fusion protein approved in the United States and Europe for the treatment of wet macular degeneration under the trade name Eylea, and for metastatic colorectal cancer as Zaltrap.
Batimastat (INN/USAN, codenamed BB-94) is an anticancer drug that belongs to the family of drugs called angiogenesis inhibitors.
Crofelemer (USAN, trade name Fulyzaq) is a drug under development for the treatment of diarrhea associated with anti-HIV drugs such as nucleoside analog reverse transcriptase inhibitors and protease inhibitors.
In the United States, generic drug substances are named through review and recommendation of the United States Adopted Names (USAN) Council.
•
Generic drugs are labeled with the name of the manufacturer and the adopted name (nonproprietary name) of the drug.
Isoprenaline (INN) or isoproterenol (USAN, trade names Medihaler-Iso and Isuprel) is a medication used for the treatment of bradycardia (slow heart rate), heart block, and rarely for asthma.
Pegdinetanib (USAN; planned trade name Angiocept) is an investigational anti-cancer drug that acts as a selective antagonist of vascular endothelial growth factor receptor 2 (VEGFR-2), hindering vascularization of tumors.
Tofogliflozin (USAN, codenamed CSG452) is an experimental drug for the treatment of diabetes mellitus and is being developed by Chugai Pharma in collaboration with Kowa and Sanofi.
This has a place in law via USP’s membership in the United States Adopted Names Council.
Vilanterol (USAN), or triphenylacetic acid, is a long-acting beta-2 agonist drug, which in May 2013 was approved in combination with fluticasone furoate for sale as Breo Ellipta by GlaxoSmithKline for the treatment of chronic obstructive pulmonary disease (COPD).
United States | United Kingdom | Republican Party (United States) | Democratic Party (United States) | United States House of Representatives | President of the United States | United Nations | United States Senate | United States Navy | United States Army | Supreme Court of the United States | United States Air Force | Native Americans in the United States | United States Congress | Parliament of the United Kingdom | 66th United States Congress | Prime Minister of the United Kingdom | 74th United States Congress | 18th United States Congress | 73rd United States Congress | 54th United States Congress | 61st United States Congress | United States Marine Corps | United States Department of Defense | 64th United States Congress | 65th United States Congress | 53rd United States Congress | 52nd United States Congress | 55th United States Congress | United States Army Corps of Engineers |
Cerlapirdine (USAN; SAM-531, WAY-262,531, PF-05212365) is a drug which is under development by Wyeth/Pfizer for the treatment of cognitive disorders associated with Alzheimer's disease and schizophrenia.